Bartlett & Co Has Decreased Procter & Gamble Co (PG) Holding By $1.23 Million, Dolby Laboratories Incclass A (DLB) SI Decreased By 3.28%

July 14, 2017 - By Vivian Park

Bartlett & Co decreased Procter & Gamble Co (PG) stake by 2.04% reported in 2016Q4 SEC filing. Bartlett & Co sold 14,641 shares as Procter & Gamble Co (PG)’s stock declined 5.32%. The Bartlett & Co holds 703,639 shares with $59.16M value, down from 718,280 last quarter. Procter & Gamble Co now has $221.08B valuation. The stock rose 0.03% or $0.03 reaching $86.73. About 764 shares traded. Procter & Gamble Co (NYSE:PG) has risen 7.54% since July 14, 2016 and is uptrending. It has underperformed by 9.16% the S&P500.

Dolby Laboratories Incclass A (NYSE:DLB) had a decrease of 3.28% in short interest. DLB’s SI was 2.57 million shares in July as released by FINRA. Its down 3.28% from 2.65 million shares previously. With 254,200 avg volume, 10 days are for Dolby Laboratories Incclass A (NYSE:DLB)’s short sellers to cover DLB’s short positions. The SI to Dolby Laboratories Incclass A’s float is 4.45%. It closed at $51.31 lastly. It is down 14.35% since July 14, 2016 and is uptrending. It has underperformed by 2.35% the S&P500.

Investors sentiment decreased to 0.85 in Q4 2016. Its down 0.03, from 0.88 in 2016Q3. It fall, as 89 investors sold PG shares while 777 reduced holdings. 122 funds opened positions while 614 raised stakes. 1.48 billion shares or 15.87% less from 1.76 billion shares in 2016Q3 were reported. 12,293 are owned by Somerset Tru Commerce. Long Road Invest Counsel Ltd, Michigan-based fund reported 6,479 shares. Windsor Financial Grp Ltd Limited Liability Company owns 65,717 shares for 2.61% of their portfolio. Guardian Life Ins Company Of America holds 0.13% or 10,254 shares. Wellington Shields And Ltd Liability Corp holds 0.59% in Procter & Gamble Co (NYSE:PG) or 13,375 shares. Eidelman Virant holds 0.44% of its portfolio in Procter & Gamble Co (NYSE:PG) for 9,207 shares. Dubuque National Bank & Trust Tru accumulated 37,278 shares or 0.56% of the stock. Comerica Comml Bank has invested 0.59% in Procter & Gamble Co (NYSE:PG). Country Club Tru Na accumulated 61,732 shares or 0.81% of the stock. Thompson Davis & Inc, a Virginia-based fund reported 7,818 shares. Lifeplan Gru stated it has 1.14% in Procter & Gamble Co (NYSE:PG). Css Lc Il owns 11,573 shares for 0.05% of their portfolio. Kings Point Cap Mgmt has 15,182 shares. Natl Asset Mgmt, New York-based fund reported 44,670 shares. Asset Mngmt Of Georgia Incorporated Ga Adv invested 0.44% of its portfolio in Procter & Gamble Co (NYSE:PG).

Bartlett & Co increased Health Care Select Sector Spdr (XLV) stake by 9,350 shares to 10,053 valued at $693,000 in 2016Q4. It also upped Nxp Semiconductor Nv (NASDAQ:NXPI) stake by 25,792 shares and now owns 199,038 shares. Vanguard Intermediate Term Cor (VCIT) was raised too.

Since February 2, 2017, it had 0 insider buys, and 19 sales for $24.25 million activity. Skoufalos Ioannis sold $334,265 worth of stock. FergusonMchugh MaryLynn sold $265,847 worth of stock. 965 shares were sold by TASTAD CAROLYN M, worth $88,011. On Wednesday, February 15 the insider Louvet Patrice sold $190,516. On Wednesday, February 15 the insider Posada Juan Fernando sold $170,232. Shares for $2.13 million were sold by Sheppard Valarie L. 2,668 shares were sold by Bishop Steven D, worth $233,011.

Analysts await Procter & Gamble Co (NYSE:PG) to report earnings on August, 1. They expect $0.79 EPS, 0.00% or $0.00 from last year’s $0.79 per share. PG’s profit will be $2.01 billion for 27.45 P/E if the $0.79 EPS becomes a reality. After $0.96 actual EPS reported by Procter & Gamble Co for the previous quarter, Wall Street now forecasts -17.71% negative EPS growth.

Among 22 analysts covering Proctor & Gamble (NYSE:PG), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Proctor & Gamble had 50 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was upgraded by Stifel Nicolaus on Tuesday, January 19 to “Buy”. The rating was downgraded by Credit Suisse on Thursday, July 30 to “Outperform”. CLSA upgraded it to “Outperform” rating and $95 target in Wednesday, October 26 report. The firm has “Neutral” rating by B. Riley & Co given on Wednesday, March 30. Deutsche Bank maintained it with “Buy” rating and $90 target in Friday, July 31 report. RBC Capital Markets maintained the shares of PG in report on Friday, June 30 with “Hold” rating. The firm earned “Sector Perform” rating on Tuesday, October 27 by RBC Capital Markets. The rating was downgraded by Suntrust Robinson on Thursday, December 22 to “Hold”. The firm has “Neutral” rating given on Wednesday, January 27 by UBS. The firm has “Overweight” rating given on Tuesday, January 26 by Morgan Stanley.

Since January 30, 2017, it had 0 insider purchases, and 13 insider sales for $5.12 million activity. DONATIELLO NICHOLAS JR sold $181,780 worth of Dolby Laboratories, Inc. (NYSE:DLB) on Friday, February 3. Shares for $250,024 were sold by YEAMAN KEVIN J. $315,000 worth of Dolby Laboratories, Inc. (NYSE:DLB) shares were sold by SHERMAN MARK ANDREW. Borchers Bob had sold 11,666 shares worth $599,350. $719,856 worth of Dolby Laboratories, Inc. (NYSE:DLB) was sold by CHEW LEWIS on Wednesday, May 17. Shares for $363,528 were sold by JASPER N WILLIAM JR on Friday, February 3. TEVANIAN AVADIS sold $181,776 worth of stock.

Among 3 analysts covering Dolby Laboratories (NYSE:DLB), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Dolby Laboratories had 4 analyst reports since October 22, 2015 according to SRatingsIntel. The stock of Dolby Laboratories, Inc. (NYSE:DLB) earned “Buy” rating by Dougherty & Company on Thursday, April 28. The firm has “Neutral” rating by B. Riley & Co given on Thursday, October 22. The rating was upgraded by Dougherty & Company to “Buy” on Thursday, January 28. The rating was downgraded by JP Morgan to “Neutral” on Friday, April 8.